Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
lisdexamfetamine
lisdexamfetamine
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Vyvanse
CAPSULE, ORAL
20 mg
Vyvanse
CAPSULE, ORAL
30 mg
Vyvanse
CAPSULE, ORAL
40 mg
Vyvanse
CAPSULE, ORAL
50 mg
Vyvanse
CAPSULE, ORAL
60 mg
Vyvanse
CAPSULE, ORAL
70 mg
VIEW MORE
Amphetamines
CLASS
282004
Additional Information:
Drug Name
Common Side Effects
Lisdexamfetamine
trouble sleeping (insomnia)
decreased appetite
feeling anxious, restless or nervous
Last updated:
Aug. 22, 2022
Black Box Warning:
High abuse/diversion potential; drug dependence
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
lisdexamfetamine
Lisdexamfetamine